These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
233 related items for PubMed ID: 15923626
1. SUMO-dependent compartmentalization in promyelocytic leukemia protein nuclear bodies prevents the access of LRH-1 to chromatin. Chalkiadaki A, Talianidis I. Mol Cell Biol; 2005 Jun; 25(12):5095-105. PubMed ID: 15923626 [Abstract] [Full Text] [Related]
2. Liver receptor homolog-1 localization in the nuclear body is regulated by sumoylation and cAMP signaling in rat granulosa cells. Yang FM, Pan CT, Tsai HM, Chiu TW, Wu ML, Hu MC. FEBS J; 2009 Jan; 276(2):425-36. PubMed ID: 19125815 [Abstract] [Full Text] [Related]
3. The PML-nuclear inclusion of human supraoptic neurons: a new compartment with SUMO-1- and ubiquitin-proteasome-associated domains. Villagra NT, Navascues J, Casafont I, Val-Bernal JF, Lafarga M, Berciano MT. Neurobiol Dis; 2006 Jan; 21(1):181-93. PubMed ID: 16125395 [Abstract] [Full Text] [Related]
4. STAT3 is enriched in nuclear bodies. Herrmann A, Sommer U, Pranada AL, Giese B, Küster A, Haan S, Becker W, Heinrich PC, Müller-Newen G. J Cell Sci; 2004 Jan 15; 117(Pt 2):339-49. PubMed ID: 14657276 [Abstract] [Full Text] [Related]
5. FRAP and FRET methods to study nuclear receptors in living cells. van Royen ME, Dinant C, Farla P, Trapman J, Houtsmuller AB. Methods Mol Biol; 2009 Jan 15; 505():69-96. PubMed ID: 19117140 [Abstract] [Full Text] [Related]
6. Role of SUMO in RNF4-mediated promyelocytic leukemia protein (PML) degradation: sumoylation of PML and phospho-switch control of its SUMO binding domain dissected in living cells. Percherancier Y, Germain-Desprez D, Galisson F, Mascle XH, Dianoux L, Estephan P, Chelbi-Alix MK, Aubry M. J Biol Chem; 2009 Jun 12; 284(24):16595-16608. PubMed ID: 19380586 [Abstract] [Full Text] [Related]
10. ZNF451 is a novel PML body- and SUMO-associated transcriptional coregulator. Karvonen U, Jääskeläinen T, Rytinki M, Kaikkonen S, Palvimo JJ. J Mol Biol; 2008 Oct 10; 382(3):585-600. PubMed ID: 18656483 [Abstract] [Full Text] [Related]
11. Analysis of in vitro SUMOylation using bioluminescence resonance energy transfer (BRET). Kim YP, Jin Z, Kim E, Park S, Oh YH, Kim HS. Biochem Biophys Res Commun; 2009 May 08; 382(3):530-4. PubMed ID: 19289109 [Abstract] [Full Text] [Related]
13. Two-step colocalization of MORC3 with PML nuclear bodies. Mimura Y, Takahashi K, Kawata K, Akazawa T, Inoue N. J Cell Sci; 2010 Jun 15; 123(Pt 12):2014-24. PubMed ID: 20501696 [Abstract] [Full Text] [Related]
14. SUMO interaction motifs in Sizn1 are required for promyelocytic leukemia protein nuclear body localization and for transcriptional activation. Cho G, Lim Y, Golden JA. J Biol Chem; 2009 Jul 17; 284(29):19592-600. PubMed ID: 19416967 [Abstract] [Full Text] [Related]
15. A fluorescence resonance energy transfer-based assay to study SUMO modification in solution. Bossis G, Chmielarska K, Gärtner U, Pichler A, Stieger E, Melchior F. Methods Enzymol; 2005 Jul 17; 398():20-32. PubMed ID: 16275316 [Abstract] [Full Text] [Related]
18. Differential expression patterns of SUMO proteins in HL-60 cancer cell lines support a role for sumoylation in the development of drug resistance. Vigodner M, Weisburg JH, Shrivastava V, Marmor RA, Fathy J, Skop N. Cell Tissue Res; 2009 May 17; 336(2):277-86. PubMed ID: 19326147 [Abstract] [Full Text] [Related]